Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Torrent Pharma eyes semaglutide launch in Brazil in 6-9 months
Torrent Pharmaceuticals plans to launch semaglutide in Brazil over the next six to nine months, as the drugmaker seeks to expand its presence in a market where revenues grew 38 per cent in the September quarter, Managing Director Aman Mehta said.
Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead
Biotech companies are high-risk, high-reward investments. Usually, a biotech has just one drug in development, and if it gets that drug to market, you win. If the drug doesn't work out, you lose. You don't have to make binary bets like that if you…
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Stock Has Average Price Target of $6.67 According to Analysts
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) has received an average recommendation of 'Moderate Buy' from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst…
After a long, strange trip, this CEO is close to taking a psilocybin pill to market
In 2022, Kabir Nath had a cushy executive job at a pharmaceutical firm that developed anti-psychotic medication. Then he got a call from a scrappy upstart with a patent on a synthetic version of psilocybin — the active ingredient in magic…
At ESMO, AstraZeneca's cancer pursuits get a showcase
MADRID — For AstraZeneca, a major oncology conference here this weekend has been a sign of how the company's cancer work is steamrolling ahead, with highlights from a mix of old standbys and new molecules that could expand its armament of…
Data security breaches rise in 2026
There were 343 such incidents throughout 2025. However, the actual number of incidents is likely to be significantly higher, as there are a large number of unreported cases, he said in an interview with the Swiss German weekly Sonntagsblick.
Bill Gates Faces Court Over Claims COVID Jabs Were 'Lethal Biological Weapons
In a packed courtroom in Leeuwarden, the official COVID story is being put on trial as Dutch plaintiffs demand personal liability from Bill Gates, Pfizer CEO Albert Bourla, former Prime Minister Mark Rutte and others for what their lawyer calls a…
Stakeholders Urge Employers to Support Women Experiencing Menopause at Work
Vanguard reported that stakeholders at the launch of Menopause At Work Africa urged public and private employers to adopt workplace policies for women experiencing perimenopause and menopause, citing stigma around discussing symptoms. Erefa Coker…
Bristlecone's 24% Growth Fuels Billion-Dollar Valuation Ambition
Discover how Mahindra Group's Bristlecone is leveraging a 24 per cent year-on-year growth and strategic AI investments to pursue a billion-dollar valuation in the competitive supply chain services market. Bristlecone, a Mahindra Group firm…
Top Growth Stocks Worth Watching - October 25th
Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Jersey Mike's are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth…
KSSP supports distribution of generic drugs for SMA patients in Keralam
Updated - October 25, 2026 01:27 pm IST - Kozhikode Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers The Kerala Sastra Sahitya Parishad (KSSP) has supported the Kerala Health Department's…
Beyond Keytruda: The Critical Pipeline Metrics to Watch in Merck's Q3 Results on Oct. 29
Pfizer carries one of Big Pharma's fattest yields while Merck burns cash on deals to secure its next growth era. Which trade-off actually serves income investors better after both companies reported earnings? Merck stock sits near analyst targets…
Why Viking Therapeutics' Oral Obesity Strategy Will Be a Make-or-Break Focus on Oct. 28
Dow Jones52,284.00−1.20% Russell 20002,778.71−0.12% Dow Jones52,284.00−1.20% Russell 20002,778.71−0.12% Dow Jones52,284.00−1.20% Russell 20002,778.71−0.12% Dow Jones52,284.00−1.20% Russell…
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Stock Now Rated 'Moderate Buy' by Sell-Side Brokerages
Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) have received an average recommendation of 'Moderate Buy' from the fourteen brokerages that are currently covering the company, Marketbeat.com reports. One analyst has…
GreensKeeper Value Fund Q3 2026 Letter
Following our strong Q2 results, the Value Fund declined 0.9% in Q3, bringing our year-to-date return to 1.0%. While headline equity indices appear to be treading water, the broader market is showing signs of meaningful strain. Bond yields have…
Receive a Daily briefing on Pharma Industry News
Get Started